HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Carcinoma of meibomian gland — Clinical Guidelines

Overview

Meibomian gland carcinoma is a rare malignancy arising from the meibomian glands of the eyelids, distinct from more common conditions like meibomian gland dysfunction (MGD). This summary focuses on the management of MGD, as direct evidence on carcinoma treatment is not provided in the abstracts.

Diagnosis

Clinical Presentation: Symptoms include ocular dryness, irritation, and visual disturbances.

Diagnostic Tests:

- Tear break-up time (TBUT) 1 3 - Oxford scale for corneal staining 1 3 - Sjögren's International Clinical Collaborative Alliance (SICCA) staining score 1 2 - Meibum quality and expressibility 1 3 - Matrix metalloproteinase-9 (MMP-9) expression in tears 1 - Ocular Surface Disease Index (OSDI) questionnaire 1 3

Grading: MGD severity can be graded using clinical scales like the MGD grading system 2.

Management

First-Line Treatments:

- Intense Pulsed Light (IPL) therapy 1 2 3 5

Adjunctive Treatments:

- Warm compresses (though not IPL-specific, often used in conjunction) 6 - Manual expression of meibomian glands 1 3

Special Populations

Pediatrics: Limited data; MGD is less common but can occur 7

Elderly: Higher meibomian lipid levels observed, potentially affecting treatment response 7

Comorbidities: No specific recommendations provided in the abstracts; general MGD management applies 1 2 3 5

Key Recommendations

IPL Therapy Improves MGD Symptoms: Intense pulsed light therapy significantly improves tear film stability, meibomian gland functionality, and patient-reported symptoms (TBUT, corneal staining, meibum quality, OSDI score) 1 3 5 (Evidence: Strong)

Acne Filter IPL Shows Promise: Use of acne filter in IPL treatment demonstrates significant improvements in clinical signs and symptoms of MGD, comparable to other filters 2 (Evidence: Moderate)

Monitor for Adverse Effects: While generally safe, monitor for potential adverse effects such as discomfort and cutaneous erythema during IPL treatment 5 (Evidence: Moderate)

Consider Age-Related Variations: Account for age-related changes in meibomian gland lipid levels when evaluating treatment efficacy 7 (Evidence: Weak)

References

1 Jang JH, Lee K, Nam SH, Kim J, Kim JY, Tchah H et al.. Comparison of clinical outcomes between intense pulsed light therapy using two different filters in meibomian gland dysfunction: prospective randomized study. Scientific reports 2023. link 2 Han JY, Lee Y, Nam S, Moon SY, Lee H, Kim JY et al.. Effect of intense pulsed light using acne filter on eyelid margin telangiectasia in moderate-to-severe meibomian gland dysfunction. Lasers in medical science 2022. link 3 Schuh A, Muth D, Shajari M, Mayer WJ, Priglinger S, Messmer E. Effect of IPL in Patients with Meibomian Gland Dysfunction. Klinische Monatsblatter fur Augenheilkunde 2021. link 4 Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunction: A concise review. The ocular surface 2020. link 5 Wladis EJ, Aakalu VK, Foster JA, Freitag SK, Sobel RK, Tao JP et al.. Intense Pulsed Light for Meibomian Gland Disease: A Report by the American Academy of Ophthalmology. Ophthalmology 2020. link 6 Matsumoto Y, Dogru M, Goto E, Ishida R, Kojima T, Onguchi T et al.. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea 2006. link 7 Chew CK, Hykin PG, Jansweijer C, Dikstein S, Tiffany JM, Bron AJ. The casual level of meibomian lipids in humans. Current eye research 1993. link

Carcinoma of meibomian gland